Lemaitre Vascular (LMAT) Enterprise Value (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Enterprise Value for 17 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value rose 16.49% year-over-year to $1.8 billion in Q2 2026; TTM through Jun 2026 was $1.8 billion, a 16.49% increase from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 16.32% from the prior year.
• Enterprise Value was $1.8 billion for Q2 2026 at Lemaitre Vascular, down from $2.1 billion in the prior quarter.
• Over five years, Enterprise Value peaked at $2.1 billion in Q1 2026 and troughed at $924.7 million in Q2 2022.
• A 5-year average of $1.4 billion and a median of $1.4 billion in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value decreased 28.87% in 2022 and surged 76.06% in 2024, its largest moves.
• Over 5 years, Enterprise Value stood at $934.2 million in 2022, then increased by 24.47% to $1.2 billion in 2023, then surged by 52.91% to $1.8 billion in 2024, then fell by 16.32% to $1.5 billion in 2025, then advanced by 22.19% to $1.8 billion in 2026.
• The last three Enterprise Value figures came in at $1.8 billion (Q2 2026), $2.1 billion (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.